Supplements, Placebo, or Rosuvastatin Study
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 203 participants.
Also called NCT04846231
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 203 participants
- Sponsor
- Registry
-
NCT04846231
-
- Other papers using this trial's data
- Comparative Effects of Low-Dose Rosuvastatin, Placebo, and Dietary Supplements on Lipids and Inflammatory Biomarkers
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT04846231. Randomized; triple masking; primary purpose treatment. Start 2021-04-23 (actual); primary completion 2022-07-19 (actual). Results posted on 2023-05-25.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Supplements, Placebo, or Rosuvastatin Study
- Acronym
- SPORT
- Condition
- Hypercholesterolemia
- Intervention (Dietary supplement)
- Fish Oil, Cinnamon, Garlique,Turmeric, Plant Sterol, Red Yeast Rice
- Intervention (Drug)
- Rosuvastatin
- Intervention (Other)
- Placebo
- Lead sponsor
- The Cleveland Clinic
- Collaborator
- AstraZeneca
Record details
- Record id
cardio:ct-nct04846231- Content hash
d05244a7b341d1d4ba6a8c8249b6d22113c204ec47ac62850c2f361b40397f42